Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Analytic Considerations for Repeated Measures of eGFR in Cohort Studies of CKD.

Shou H, Hsu JY, Xie D, Yang W, Roy J, Anderson AH, Landis JR, Feldman HI, Parsa A, Jepson C; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

Clin J Am Soc Nephrol. 2017 Jul 27. pii: CJN.11311116. doi: 10.2215/CJN.11311116. [Epub ahead of print]

PMID:
28751576
2.

Association of Kidney Function and Early Kidney Injury With Incident Hypertension in HIV-Infected Women.

Ascher SB, Scherzer R, Peralta CA, Tien PC, Grunfeld C, Estrella MM, Abraham A, Gustafson DR, Nowicki M, Sharma A, Cohen MH, Butch AW, Young MA, Bennett MR, Shlipak MG.

Hypertension. 2017 Feb;69(2):304-313. doi: 10.1161/HYPERTENSIONAHA.116.08258. Epub 2016 Dec 19.

PMID:
27993956
3.

Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults.

Sakoda ME, Fazeli PL, Ellis RJ, Jeste DV, Grant I, Letendre SL, Moore DJ.

J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):243-249. doi: 10.1097/QAI.0000000000001235.

PMID:
27861242
4.

Prevalence and predictors of chronic kidney disease in newly diagnosed human immunodeficiency virus patients in Owerri, Nigeria.

Anyabolu EN, Chukwuonye II, Arodiwe E, Ijoma CK, Ulasi I.

Indian J Nephrol. 2016 Jan-Feb;26(1):10-5. doi: 10.4103/0971-4065.156115.

5.

Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series.

Waheed S, Attia D, Estrella MM, Zafar Y, Atta MG, Lucas GM, Fine DM.

Clin Kidney J. 2015 Aug;8(4):420-5. doi: 10.1093/ckj/sfv041. Epub 2015 Jun 3.

6.

Epidemiology, clinical characteristics, and management of chronic kidney disease in human immunodeficiency virus-infected patients.

Ando M, Yanagisawa N.

World J Nephrol. 2015 Jul 6;4(3):388-95. doi: 10.5527/wjn.v4.i3.388. Review.

7.

Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy.

Bandera A, Gori A, Sabbatini F, Madeddu G, Bonora S, Libertone R, Mastroianni C, Bonfanti P, d'Arminio Monforte A, Cozzi-Lepri A; Icona Foundation Study Group.

PLoS One. 2015 May 1;10(5):e0124252. doi: 10.1371/journal.pone.0124252. eCollection 2015.

8.

Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study.

Abraham AG, Darilay A, McKay H, Margolick JB, Estrella MM, Palella FJ Jr, Bolan R, Rinaldo CR, Jacobson LP.

J Infect Dis. 2015 Oct 1;212(7):1100-10. doi: 10.1093/infdis/jiv159. Epub 2015 Mar 11.

9.

Relationships between renal parameters and serum and urine markers of inflammation in those with and without HIV infection.

Shinha T, Mi D, Liu Z, Orschell CM, Lederman MM, Gupta SK.

AIDS Res Hum Retroviruses. 2015 Apr;31(4):375-83. doi: 10.1089/AID.2014.0234. Epub 2015 Feb 26.

10.

Association of urine α1-microglobulin with kidney function decline and mortality in HIV-infected women.

Jotwani V, Scherzer R, Abraham A, Estrella MM, Bennett M, Cohen MH, Nowicki M, Sharma A, Young M, Tien PC, Ix JH, Sarnak MJ, Parikh CR, Shlipak MG.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):63-73. doi: 10.2215/CJN.03220314. Epub 2014 Nov 4.

11.

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Lucas GM, Ross MJ, Stock PG, Shlipak MG, Wyatt CM, Gupta SK, Atta MG, Wools-Kaloustian KK, Pham PA, Bruggeman LA, Lennox JL, Ray PE, Kalayjian RC; HIV Medicine Association of the Infectious Diseases Society of America.

Clin Infect Dis. 2014 Nov 1;59(9):e96-138. doi: 10.1093/cid/ciu617. Epub 2014 Sep 17.

12.

Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals.

Kalayjian RC, Wu K, Evans S, Clifford DB, Pallaki M, Currier JS, Smryzynski M.

J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):30-5. doi: 10.1097/QAI.0000000000000237.

13.

Race and other risk factors for incident proteinuria in a national cohort of HIV-infected veterans.

Banerjee T, Scherzer R, Powe NR, Steffick D, Shahinian V, Saran R, Pavkov ME, Saydah S, Shlipak MG; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):145-52. doi: 10.1097/QAI.0000000000000285.

14.

Impaired Urine Dilution Capability in HIV Stable Patients.

Belloso WH, de Paz Sierra M, Navarro M, Sanchez ML, Perelsztein AG, Musso CG.

Int J Nephrol. 2014;2014:381985. doi: 10.1155/2014/381985. Epub 2014 Mar 31.

15.

Screening for decreased glomerular filtration rate and associated risk factors in a cohort of HIV-infected patients in a middle-income country.

Santiago P, Grinsztejn B, Friedman RK, Cunha CB, Coelho LE, Luz PM, de Oliveira AV, Moreira RI, Cardoso SW, Veloso VG, Suassuna JH.

PLoS One. 2014 Apr 3;9(4):e93748. doi: 10.1371/journal.pone.0093748. eCollection 2014.

16.

Does HIV infection promote early kidney injury in women?

Jotwani V, Scherzer R, Abraham A, Estrella MM, Bennett M, Devarajan P, Anastos K, Cohen MH, Nowicki M, Sharma A, Young M, Tien PC, Grunfeld C, Parikh CR, Shlipak MG.

Antivir Ther. 2014;19(1):79-87. doi: 10.3851/IMP2677. Epub 2013 Aug 23.

17.

Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women.

Driver TH, Scherzer R, Peralta CA, Tien PC, Estrella MM, Parikh CR, Butch AW, Anastos K, Cohen MH, Nowicki M, Sharma A, Young MA, Abraham A, Shlipak MG.

AIDS. 2013 Sep 10;27(14):2291-9. doi: 10.1097/QAD.0b013e328362e874.

18.

Total protein, albumin and low-molecular-weight protein excretion in HIV-positive patients.

Campbell LJ, Dew T, Salota R, Cheserem E, Hamzah L, Ibrahim F, Sarafidis PA, Moniz CF, Hendry BM, Poulton M, Sherwood RA, Post FA.

BMC Nephrol. 2012 Aug 10;13:85. doi: 10.1186/1471-2369-13-85.

19.

Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients.

Ibrahim F, Hamzah L, Jones R, Nitsch D, Sabin C, Post FA; UK Collaborative HIV Cohort (CHIC)/CKD Study Group.

Am J Kidney Dis. 2012 Oct;60(4):539-47. doi: 10.1053/j.ajkd.2012.03.006. Epub 2012 Apr 21.

20.

Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic population.

Rawlings MK, Klein J, Klingler EP, Queen E, Rogers L, Yau LH, Pappa KA, Pakes GE.

HIV AIDS (Auckl). 2011;3:1-8. doi: 10.2147/HIV.S13902. Epub 2011 Jan 28.

Supplemental Content

Support Center